PANOVA-3: A phase III study of tumor treating fields with nabpaclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC).

Authors

null

Uri Weinberg

Novocure Ltd., Haifa, Israel

Uri Weinberg , Moshe Giladi , Zeev Bomzon , Eilon David Kirson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT03377491

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr TPS469)

DOI

10.1200/JCO.2019.37.4_suppl.TPS469

Abstract #

TPS469

Poster Bd #

Q8

Abstract Disclosures

Similar Posters

First Author: Vincent J. Picozzi

First Author: Vincent J. Picozzi

First Author: Vincent J. Picozzi

First Author: Vincent J. Picozzi